Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Evaluation of ChatGPT’s Potential in Tailoring Gynecological Cancer Therapies

ANNIKA KRÜCKEL, LENA BRÜCKNER, IASON PSILOPATIS, PETER A. FASCHING, MATTHIAS W. BECKMANN and JULIUS EMONS
In Vivo July 2024, 38 (4) 1649-1659; DOI: https://doi.org/10.21873/invivo.13614
ANNIKA KRÜCKEL
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LENA BRÜCKNER
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IASON PSILOPATIS
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER A. FASCHING
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTHIAS W. BECKMANN
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JULIUS EMONS
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: julius.emons{at}uk-erlangen.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 4 1649-1659
DOI 
https://doi.org/10.21873/invivo.13614
PMID 
38936938

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received January 24, 2024
  • Revision received March 3, 2024
  • Accepted March 19, 2024
  • Published online June 27, 2024.

Copyright & License 
Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. ANNIKA KRÜCKEL,
  2. LENA BRÜCKNER,
  3. IASON PSILOPATIS,
  4. PETER A. FASCHING,
  5. MATTHIAS W. BECKMANN and
  6. JULIUS EMONS⇑
  1. Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  1. Correspondence to: Julius Emons, Universitätsstraße 21-23, 91054 Erlangen, Germany. Tel: +49 91318533553, e-mail: julius.emons{at}uk-erlangen.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 16 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo: 38 (4)
In Vivo
Vol. 38, Issue 4
July-August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of ChatGPT’s Potential in Tailoring Gynecological Cancer Therapies
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
18 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Evaluation of ChatGPT’s Potential in Tailoring Gynecological Cancer Therapies
ANNIKA KRÜCKEL, LENA BRÜCKNER, IASON PSILOPATIS, PETER A. FASCHING, MATTHIAS W. BECKMANN, JULIUS EMONS
In Vivo Jul 2024, 38 (4) 1649-1659; DOI: 10.21873/invivo.13614

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Evaluation of ChatGPT’s Potential in Tailoring Gynecological Cancer Therapies
ANNIKA KRÜCKEL, LENA BRÜCKNER, IASON PSILOPATIS, PETER A. FASCHING, MATTHIAS W. BECKMANN, JULIUS EMONS
In Vivo Jul 2024, 38 (4) 1649-1659; DOI: 10.21873/invivo.13614
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting
  • Leveraging Large Language Models in Gynecologic Oncology: A Systematic Review of Current Applications and Challenges
  • Google Scholar

More in this TOC Section

  • Time-course Investigation of Bone and Disc Degeneration in a Rat Model of Pyogenic Spondylodiscitis
  • Plasma Exosomal miR-106b-5p Is Associated With Osteoporosis by Targeting SMAD5, BMP2, and MAPK1 Genes
  • Exercise Stimulates PINK-1, PARKIN, MFN-1, and ATG-3 Genes Expression Despite High-fat Diet: Tissue-specific Responses
Show more Experimental Studies

Keywords

  • Artificial intelligence
  • ChatGPT
  • ovarian cancer
  • cervical cancer
  • Endometrial cancer
In Vivo

© 2026 In Vivo

Powered by HighWire